The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Genetics in Medicine

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/GIM.0b013e3181b13a6cPMID 19617843PMCID PMC2936269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Handbook of cancer control and behavioral science : a resource for researchers, practitioners, and policy makers

  2009cited by this paper
• Evaluating the utility of personal genomic information

  2009cited by this paper
• Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence

  2009cited by this paper
• Secretary's Advisory Committee on Genetics, Health, and Society—Public Consultation Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests (Draft Report for Public Comment) [excerpts]

  2009cited by this paper
• Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3

  2009cited by this paper
• Interpretation of Genetic Association Studies: Markers with Replicated Highly Significant Odds Ratios May Be Poor Classifiers

  2009cited by this paper
• Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation

  2009cited by this paper
• Beyond odds ratios — communicating disease risk based on genetic profiles

  2009cited by this paper
• Estimation of the warfarin dose with clinical and pharmacogenetic data.

  2009cited by this paper
• Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?

  2009cited by this paper
• The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

  2009cited by this paper
• Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

  2009cited by this paper
• Meta-analysis in genome-wide association studies.

  2009cited by this paper
• Disclosure of APOE genotype for risk of Alzheimer's disease.

  2009cited by this paper
• The Genomic Applications in Practice and Prevention Network

  2009cited by this paper
• Pharmacogenetics--tailoring treatment for the outliers.

  2009cited by this paper
• Cohort studies and the genetics of complex disease

  2009cited by this paper
• Psychosocial Aspects of DNA Testing for Hereditary Hemochromatosis in At-Risk Individuals: A Systematic Review

  2009cited by this paper
• Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study

  2009cited by this paper
• Personalized Genetic Prediction: Too Limited, Too Expensive, or Too Soon?

  2009cited by this paper
• Overview, current status, and future directions.

  2009cited by this paper
• A Health Services Research Agenda for Cellular, Molecular and Genomic Technologies in Cancer Care

  2009cited by this paper
• The evidence dilemma in genomic medicine.

  2008cited by this paper
• A HapMap harvest of insights into the genetics of common disease.

  2008cited by this paper
• General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

  2008cited by this paper
• Genetic Mapping in Human Disease

  2008cited by this paper
• Looking to the Future of New Media in Health Marketing: Deriving Propositions Based on Traditional Theories

  2008cited by this paper
• Assessing the Value of Risk Predictions by Using Risk Stratification Tables

  2008cited by this paper
• Size matters: just how big is BIG?

  2008cited by this paper
• Pharmacogenomics--ready for prime time?

  2008cited by this paper
• Putting science over supposition in the arena of personalized genomics

  2008cited by this paper
• Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

  2008cited by this paper
• Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association Studies

  2008cited by this paper
• Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature

  2008cited by this paper
• US system of oversight for genetic testing: a report from the Secretary's Advisory Committee on Genetics, Health and Society.

  2008cited by this paper
• Genome-based prediction of common diseases: advances and prospects.

  2008cited by this paper
• Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men.

  2008cited by this paper
• Pharmacogenomics: candidate gene identification, functional validation and mechanisms.

  2008cited by this paper
• Assessment of cumulative evidence on genetic associations: interim guidelines.

  2008cited by this paper
• Genome-wide association studies for complex traits: consensus, uncertainty and challenges

  2008cited by this paper
• Assessing the Combined Impact of 18 Common Genetic Variants of Modest Effect Sizes on Type 2 Diabetes Risk

  2008cited by this paper
• Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.

  2008cited by this paper
• Pharmacogenomic dosing of warfarin: ready or not?

  2008cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Time to check CHEK2 in families with breast cancer?

  2008cited by this paper
• The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes

  2008cited by this paper
• Predictors of Attrition and Weight Loss in an Adolescent Weight Control Program

  2008cited by this paper
• Health Behavior Changes After Genetic Risk Assessment for Alzheimer Disease: The REVEAL Study

  2008cited by this paper
• Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer.

  2008cited by this paper
• Quantifying realistic sample size requirements for human genome epidemiology

  2008cited by this paper
• Personal genomes: Misdirected precaution

  2008cited by this paper
• Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929)

  2008cited by this paper
• Genomic profiles for disease risk: predictive or premature?

  2008cited by this paper
• Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929)

  2008cited by this paper
• Can fishing for new genes catch patients at risk of coronary artery disease?

  2008cited by this paper
• Abstract 5090: Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Risk Classification for Coronary Heart Disease and Implications for Lipid-Modifying Therapy in the White Population of the Atherosclerosis Risk in Communities (ARIC) Study

  2008cited by this paper
• An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons.

  2008cited by this paper
• The genome gets personal--almost.

  2008cited by this paper
• Letting the genome out of the bottle--will we get our wish?

  2008cited by this paper
• A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions.

  2008cited by this paper
• A navigator for human genome epidemiology

  2008cited by this paper
• Rare independent mutations in renal salt handling genes contribute to blood pressure variation

  2008cited by this paper
• The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases

  2007cited by this paper
• Integrating the predictiveness of a marker with its performance as a classifier.

  2007cited by this paper
• The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?

  2007cited by this paper
• Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors

  2007cited by this paper
• Risky Communication: Pitfalls in Counseling About Risk, and How to Avoid Them

  2007cited by this paper
• Evidence based medicine meets genomic medicine

  2007cited by this paper
• Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction

  2007cited by this paper
• Counterpoint: Genetic Risk Feedback for Common Disease—Time to Test the Waters

  2007cited by this paper
• Turning the pump handle: evolving methods for integrating the evidence on gene-disease association.

  2007cited by this paper
• Using wireless handheld computers and tailored text messaging to reduce negative consequences of drinking alcohol.

  2007cited by this paper
• Point: Genetic Risk Feedback for Common Disease—Time to Test the Waters

  2007cited by this paper
• Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.

  2006cited by this paper
• Pharmacogenetics and pharmacogenomics: development, science, and translation.

  2006cited by this paper
• What is the clinical utility of genetic testing?

  2006cited by this paper
• When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials?

  2006cited by this paper
• Developing a center for comparative effectiveness information.

  2006cited by this paper
• Effects of attributing serious mental illnesses to genetic causes on orientations to treatment.

  2006cited by this paper
• Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research.

  2006cited by this paper
• Genetic susceptibility testing versus family history–based risk assessment: Impact on perceived risk of Alzheimer disease

  2005cited by this paper
• Blazing a Trail: A Public Health Research Agenda in Genomics and Chronic Disease

  2005cited by this paper
• Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior.

  2005cited by this paper
• On criteria for evaluating models of absolute risk.

  2005cited by this paper
• Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial

  2004cited by this paper
• Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial

  2004cited by this paper
• A Meta-Analysis of the Effect of Mediated Health Communication Campaigns on Behavior Change in the United States

  2004cited by this paper
• The case for a global human genome epidemiology initiative

  2004cited by this paper
• Population screening in the age of genomic medicine.

  2003cited by this paper
• Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the β3-adrenergic receptor gene

  2003cited by this paper
• Simple tools for understanding risks: from innumeracy to insight

  2003cited by this paper
• Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change.

  1997cited by this paper
• Summary of Recommendations: The Evaluation of Genomic Applications

  year unknowncited by this paper

• Development and validation of a genetic probability for venous thromboembolism

  2025cites this paper
• Estimating Cancer Penetrance in Carriers of BRCA2 Pathogenic Variants Using Cancer‐Specific Polygenic Scores

  2025cites this paper
• The Role of Online Support, Caregiving, and Gender in Preventative Cancer Genetic Testing Participation: Cross-Sectional Study From a National Study

  2024cites this paper
• Handwashing Practices among Public Primary School Students in East Dembiya District, Ethiopia.

  2024cites this paper
• Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms

  2022cites this paper
• Preventive population genomics: The model of BRCA related cancers.

  2021cites this paper
• The attitude of young people in the city of Yakutsk to DNA-testing

  2021cites this paper
• Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews

  2021cites this paper
• Consumer Testing for Disease Risk: ACOG Committee Opinion Summary, Number 816.

  2021cites this paper
• Population-based Genetic Testing for Precision Prevention

  2020cites this paper
• Exploring the Current Landscape of Consumer Genomics

  2020cites this paper
• Molecular Profiling of Advanced Malignancies: A Community Oncology Network Experience and Review of Literature

  2020cites this paper
• The evidence landscape in precision medicine

  2020cites this paper
• How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?

  2020cites this paper
• Research participants’ experiences with return of genetic research results and preferences for web‐based alternatives

  2019cites this paper
• Does genetic risk for common adult diseases influence reproductive plans? Evidence from a national survey experiment in the United States.

  2018cites this paper
• Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial

  2018cites this paper
• The American College of Obstetricians and Gynecologists

  2018cites this paper
• U.S. Physician–Scientist Workforce in the 21st Century: Recommendations to Attract and Sustain the Pipeline

  2017cites this paper
• Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial

  2017cites this paper
• Providing Unrestricted Access to Prenatal Testing Does Not Translate to Enhanced Autonomy

  2017cites this paper
• Development of the Personal Genomics Industry

  2017cites this paper
• From public health genomics to precision public health: a 20-year journey

  2017cites this paper
• Pediatric Oncology: A Model Of Innovation Through Collaboration

  2017cites this paper
• The attitudes of Dutch fertility specialists towards the addition of genetic testing in screening of tubal factor infertility.

  2017cites this paper
• Factors influencing and modifying the decision to pursue genetic testing for skin cancer risk

  2017cites this paper
• Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity

  2017cites this paper
• Genomic newborn screening: public health policy considerations and recommendations

  2017cites this paper
• Committee Opinion No. 724: Consumer Testing for Disease Risk.

  2017cites this paper
• Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications.

  2016cites this paper
• Defining Ourselves: Personal Bioinformation as a Tool of Narrative Self-Conception

  2016cites this paper
• Does a medical history of hypertension influence disclosing genetic testing results of the risk for salt-sensitive hypertension, in primary care?

  2016cites this paper
• 12. Personalized orthodontics

  2015cites this paper
• UK users' and genetics clinicians' experiences of direct-to-consumer genetic testing

  2015cites this paper
• 23andMe and the FDA: Negotiating Conceptions of Benefit in the Direct-to-Consumer Genetic Testing Regulatory Debate

  2015cites this paper
• Disabling Pregnancy: Revealing how prenatal testing messages shape reproductive choices

  2015cites this paper
• The future of personalized and precision perinatal medicine. Foreword.

  2015cites this paper
• Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders

  2015cites this paper
• Ethical Challenges to Next-Generation Sequencing

  2015cites this paper
• Participant Satisfaction With a Preference-Setting Tool for the Return of Individual Research Results in Pediatric Genomic Research

  2015cites this paper
• Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders

  2015cites this paper
• Explaining, not just predicting, drives interest in personal genomics

  2015cites this paper
• Reconceptualizing Consent for Direct-to-Consumer Health Services

  2015cites this paper
• The Development of a Preference-Setting Model for the Return of Individual Genomic Research Results

  2015cites this paper
• Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbidities.

  2015cites this paper
• Obesity, More than a ‘Cosmetic’ Problem. Current Knowledge and Future Prospects of Human Obesity Genetics

  2015cites this paper
• Personal utility in genomic testing: is there such a thing?

  2014cites this paper
• Genome Analysis Workshop: a Personal Genomics Class at Keio SFC

  2014cites this paper
• Parents' Preferences for Return of Results in Pediatric Genomic Research

  2014cites this paper
• Biomarker Discovery and Development through Genomics

  2014cites this paper
• Overview of a chemoresponse assay in ovarian cancer

  2014cites this paper
• Personal genomic information management and personalized medicine: challenges, current solutions, and roles of HIM professionals.

  2014cites this paper
• Knowledge and attitudes to personal genomics testing for complex diseases among Nigerians

  2014cites this paper
• Cancer Screening and Genetics: A Tale of Two Paradigms

  2014cites this paper
• Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent.

  2014cites this paper
• Genetics and primary care: where are we headed?

  2014cites this paper
• Concerns about unintended negative consequences of informing the public about multifactorial risks may be premature for young adult smokers.

  2014cites this paper
• The Incorporation of Predictive Genomic Testing into Genetic Counseling Programs

  2014cites this paper
• Development of a Communication Protocol for Telephone Disclosure of Genetic Test Results for Cancer Predisposition

  2014cites this paper
• Guidelines for return of research results from pediatric genomic studies: deliberations of the Boston Children’s Hospital Gene Partnership Informed Cohort Oversight Board

  2014cites this paper
• Characteristics associated with informed consent for genetic studies in the ACCORD trial.

  2014cites this paper
• Up Close and Personal : Ethical issues in genomic testing

  2014cites this paper
• Labouring towards self-fulfilment: personal genomics and the ‘participatory turn’

  2014cites this paper
• The changing landscape of genetic testing for hereditary breast and ovarian cancer.

  2014cites this paper
• Genetic determinants of cardiovascular disease : heritability and genetic risk score

  2014cites this paper
• UWA Research Publication

  2013cites this paper
• Family History and Health Risk Assessment

  2013cites this paper
• Challenges for the regulatory agencies in establishing an environment favorable for stratified medicine

  2013cites this paper
• Adapting Quantitative Protein and Phosphorylation Analyses to a Proteome-Wide Scale

  2013influential citation
• Challenges and Regulation of Direct to Consumer Testing

  2013cites this paper
• Walking the tightrope: Expectations and standards in personal genomics

  2013cites this paper
• Genomic Medicine: A Decade of Successes, Challenges, and Opportunities

  2013cites this paper
• Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations

  2013cites this paper
• Direct-to-consumer genomic testing from the perspective of the health professional: a systematic review of the literature

  2013cites this paper
• Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.

  2013cites this paper
• Primary care patient willingness for genetic testing for salt-sensitive hypertension: a cross sectional study

  2013cites this paper
• Primary care patients’ views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study

  2013cites this paper
• Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis

  2013cites this paper
• Development and Evaluation of a Genetic Risk Score for Obesity

  2013cites this paper
• Clinical utility of genetic risk testing in primary care: the example of Type 2 diabetes.

  2013cites this paper
• Public opinion on policy issues in genetics and genomics

  2013cites this paper
• How can polygenic inheritance be used in population screening for common diseases?

  2013cites this paper
• Clinical decision support for genetically guided personalized medicine: a systematic review

  2013cites this paper
• Integration of genomic medicine into pathology residency training: the stanford open curriculum.

  2013cites this paper
• Formulating a Curriculum on Aging and Health for University Undergraduates

  2013cites this paper
• An Empirical Evaluation of Normalization Methods for MicroRNA Arrays in a Liposarcoma Study

  2013cites this paper
• Allgemeine Grundlagen der Tumorbiologie in der Viszeralchirurgie

  2013cites this paper
• “Is it Really Worth it to Get Tested?”: Primary Care Patients’ Impressions of Predictive SNP Testing for Colon Cancer

  2013cites this paper
• Biobanking: sample acquisition and quality assurance for 'omics' research.

  2013cites this paper
• A Community Standard for Immunogenomic Data-reporting and Analysis: Proposal for a STrengthening the REporting of Immunogenomic Studies (STREIS) statement

  2013cites this paper
• Stratified medicine: a new era in the therapeutic approach

  2013cites this paper
• Bridging the Communication Divide: A Role for Health Psychology in the Genomic Era.

  2012cites this paper
• A Comparative Analysis of Indigenous Research Guidelines to Inform Genomic Research in Indigenous Communities

  2012cites this paper
• Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice

  2012cites this paper
• The Informed Cohort Oversight Board: From Values to Architecture.

  2012cites this paper
• Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology.

  2012cites this paper
• Beyond base pairs to bedside: a population perspective on how genomics can improve health.

  2012cites this paper
• Using genetic information in risk prediction for alcohol dependence

  2012cites this paper
• Informing public health approaches to obesity and smoking using genome-wide association studies: Genetic epidemiology affirms the importance of early prevention

  2012cites this paper
• Cardiovascular epidemiology in a changing world--challenges to investigators and the National Heart, Lung, and Blood Institute.

  2012cites this paper